Skip to content

Early Detection of Brain Injury After Congenital Heart Surgery in Infants

Early Detection of Brain Damage in Children With Congenital Heart Disease After Cardiovascular Surgery

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07424976
Enrollment
30
Registered
2026-02-20
Start date
2024-05-03
Completion date
2026-09-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease (CHD), Hypoxic Encephalopathy

Keywords

Secretoneurin, GFAP, Neuron-specific enolase, S100B, UCHL-1, Neurofilament light chain, MRI, Cardiopulmonary bypass

Brief summary

Infants with congenital heart disease undergoing cardiac surgery with extracorporeal circulation are at risk for perioperative hypoxic-ischaemic brain injury. This prospective, single-centre observational cohort study will evaluate perioperative dynamics of serum biomarkers of neuronal, glial, and axonal injury and relate biomarker patterns to postoperative EEG changes and brain MRI findings, aiming to improve early detection of brain injury and identify children at higher risk of hypoxic encephalopathy.

Detailed description

This prospective observational study will enrol 30 children up to 1 year of age with congenital heart disease requiring surgery with extracorporeal circulation at a single paediatric intensive care centre. After parental/guardian consent, peripheral blood will be collected for ELISA measurement of secretoneurin, GFAP, neuron-specific enolase, S100B, UCHL-1, neurofilament light chain, and total tau at the following time points: within 24 hours preoperatively; 1 hour after arrival from the operating theatre; and 24, 48, 72, 96 hours and 7 days postoperatively. All participants will undergo EEG within the first 24 hours and on postoperative day 7. Between postoperative week 1 and week 2, 15 participants will undergo brain MRI under sedation or general anaesthesia. Perioperative and postoperative clinical variables will be abstracted (e.g., cardiopulmonary bypass duration, major artery clamp duration, inotrope/vasoactive support, arrhythmias, and markers of organ hypoperfusion including lactate and regional oxygen saturation). Associations between biomarker trajectories and EEG/MRI evidence of brain injury will be assessed using repeated-measures modelling; ROC analyses will explore biomarker thresholds where applicable.

Interventions

OTHERObservational study: blood analisys, EEG, MRI

Observational study: blood analisys, EEG, MRI

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Days to 1 Years
Healthy volunteers
No

Inclusion criteria

* Infants/children up to 1 year of age with congenital heart disease undergoing surgery requiring extracorporeal blood circulation (cardiopulmonary bypass).

Exclusion criteria

* Congenital heart disease not requiring extracorporeal circulation during surgery * Inoperable congenital heart defect * Hypoxic encephalopathy at birth requiring therapeutic hypothermia

Design outcomes

Primary

MeasureTime frameDescription
Concentration of serum brain injury biomarker concentrations (ELISA panel)Within 24 hours pre-op; 1 hour post-op arrival; 24, 48, 72, 96 hours; and 7 days post-op.Serum concentrations of secretoneurin, GFAP, NSE, S100B, UCHL-1, neurofilament light chain, and total tau measured in peripheral blood.
Number of Participants with postoperative EEG abnormalitiesPost-op day 0-1 and post-op day 7EEG findings assessed within the first 24 hours and on postoperative day 7
Presence and types of intracranial injuries seen on brain MRI (subset)Post-op week 1-2.Presence/type/frequency of brain MRI findings performed in a subset of 15 participants between postoperative week 1 and week 2

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026